SPX3,786.99-31.84 -0.83%
DIA307.46-2.59 -0.84%
IXIC11,048.24-129.65 -1.16%

BioNTech Whale Trades For June 10

A whale with a lot of money to spend has taken a noticeably bearish stance on BioNTech. Looking at options history for BioNTech (NASDAQ:BNTX) we detected 10 strange trades.

Benzinga · 06/10/2022 16:38

A whale with a lot of money to spend has taken a noticeably bearish stance on BioNTech.

Looking at options history for BioNTech (NASDAQ:BNTX) we detected 10 strange trades.

If we consider the specifics of each trade, it is accurate to state that 30% of the investors opened trades with bullish expectations and 70% with bearish.

From the overall spotted trades, 7 are puts, for a total amount of $924,470 and 3, calls, for a total amount of $219,267.

What's The Price Target?

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $120.0 to $155.0 for BioNTech over the last 3 months.

Volume & Open Interest Development

Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.

This data can help you track the liquidity and interest for BioNTech's options for a given strike price.

Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of BioNTech's whale activity within a strike price range from $120.0 to $155.0 in the last 30 days.

BioNTech Option Volume And Open Interest Over Last 30 Days

Options Call Chart

Biggest Options Spotted:

 

Symbol PUT/CALL Trade Type Sentiment Exp. Date Strike Price Total Trade Price Open Interest Volume
BNTX PUT SWEEP BEARISH 09/16/22 $120.00 $312.0K 2 1.0K
BNTX PUT SWEEP BULLISH 09/16/22 $120.00 $258.9K 2 400
BNTX PUT TRADE BULLISH 12/16/22 $130.00 $140.7K 1.3K 70
BNTX CALL TRADE BEARISH 12/16/22 $150.00 $130.0K 0 50
BNTX PUT SWEEP BEARISH 09/16/22 $125.00 $65.2K 0 170

Where Is BioNTech Standing Right Now?

  • With a volume of 872,644, the price of BNTX is down -4.93% at $141.91.
  • RSI indicators hint that the underlying stock may be approaching oversold.
  • Next earnings are expected to be released in 59 days.

What The Experts Say On BioNTech:

  • Goldman Sachs has decided to maintain their Neutral rating on BioNTech, which currently sits at a price target of $206.

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.

If you want to stay updated on the latest options trades for BioNTech, Benzinga Pro gives you real-time options trades alerts.